CHRISTOPHER HOWELL: Open Payments
NPI 1033704812 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 83 payments from 15 companies in 2025. Trend: 2023 $1,521 · 2024 $1,368 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 26 | $274 |
| Amgen Inc. | 14 | $230 |
| AstraZeneca Pharmaceuticals LP | 7 | $162 |
| ABBVIE INC. | 5 | $92 |
| Lilly USA, LLC | 5 | $88 |
| Esperion Therapeutics, Inc. | 4 | $72 |
| Almatica Pharma LLC | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 7 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Exact Sciences Corporation | 3 | $47 |
Products named: OTEZLA, Wegovy, Ozempic, MOUNJARO, EVENITY, NEXLETOL, UBRELVY, LOREEV XR.
Industry payments across KY — which companies pay providers there.
